NORTHBROOK, Ill.--(BUSINESS WIRE)--Blue Chip Patient Recruitment, a global, full-service strategic marketing practice of Blue Chip Marketing Worldwide that specializes in accelerating enrollment of clinical trials, has announced results of its latest research study on how physicians and clinical trial coordinators can successfully accelerate enrollment of pediatric clinical trials.
The white paper, titled “Accelerating Recruitment for Pediatric Clinical Trials: Connecting Parents, Children and Investigators” and available at www.bcpatientrecruitment.com/whitepaper, summarizes the results of primary market research that explores the motivations and barriers a parent faces when considering clinical trial opportunities for their child and the challenges physicians experience when recruiting children for clinical trials.
“Understanding the true motivations and worries behind a parent’s decision to enroll their child in a clinical trial is essential for successful enrollment,” says Neil Weisman, EVP/general manager of Blue Chip Patient Recruitment. “With adult conditions starting to emerge in children more frequently and since many medications have never been studied in children, sponsors and investigators will need this type of research to successfully address changing pediatric healthcare needs.”
Key findings include:
The study shows that even though parents may be very or somewhat satisfied with their child’s current medication, physicians should always educate and inform parents of potential clinical trial opportunities. Nearly 85% of the parents who were “very or somewhat satisfied” with their child’s current medication indicated they would be willing to switching their child to a new medication option.
To better connect with parents, physicians should focus on how the trial can potentially benefit their child as opposed to more altruistic-based communications. More than 53% of parents cited “my child might benefit” as their top motivation for enrolling their child in a clinical trial while 74% of physicians chose “benefit other children in the future” as their main point when educating parents on clinical trial opportunities.
Physicians need to understand and create communications based on how their patients’ parents prefer to receive information about potential pediatric clinical trial opportunities. Listed as the most preferred method of communications, 46% of parents indicated they prefer to receive information about pediatric clinical trial opportunities from their physicians by email, whereas only 6% of physicians stated that email was the most effective way to communicate with parents. And while not one doctor stated a physical letter was effective, nearly 30% of parents preferred to receive clinical trial information via a physical letter.
Weisman will present complete results and analysis during his presentation titled “Overcoming Unique Challenges of Pediatric Studies” at the Drug Information Association (DIA) 49th annual meeting in Boston, Mass. on June 26, 2013, at 4 pm ET. The full results of the white paper are available for download at www.bcpatientrecruitment.com/whitepaper and by visiting booth #2013 at the Boston Convention Center during DIA.
Blue Chip Patient Recruitment conducted an online quantitative research study in February and March of 2013. More than 500 parent respondents were parents of children with at least one of the following pediatric disease conditions: ADHD, ADD, asthma, allergies, Type 1 and Type 2 diabetes, depression, hypertension or high cholesterol. Additionally 60 physicians who have participated in pediatric clinical trials within the past five years were surveyed.
About Blue Chip Patient Recruitment
Blue Chip Patient Recruitment, a specialized practice of Blue Chip Marketing Worldwide, is a global, full-service strategic marketing patient recruitment and retention agency dedicated to accelerating clinical trial enrollment. For more than 20 years, Blue Chip Patient Recruitment has integrated its scientific approach to clinical trials with its strategic marketing expertise in direct response, creative, digital and media planning to successfully motivate qualified patients to action. Blue Chip Patient Recruitment has helped nearly 600 clinical trials in more than 65 disease states, consistently meeting and exceeding clients' objectives. For more information, visit bcpatientrecruitment.com
